Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Struthers Richard Scott exercised options for 19,928 Crinetics Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 11, 2026
On Aug 7, 2026, Struthers Richard Scott (Director, President & CEO) exercised options for 19,928 Crinetics Pharmaceuticals, Inc. shares at an average US$20.07 for US$400K, leaving 424,706 shares. Filed Aug 11, 2026 (Form 4).
- Options exercised
- 19,928 shares
- Price
- US$20.07 average (US$15.29 to US$25.19)
- Value
- US$400K
- Holding after
- 424,706 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Option exercise | 3,969 | US$25.19 | 408,747 | Direct |
| Aug 7, 2026 | Common Stock | Option exercise | 4,422 | US$22.61 | 413,169 | Direct |
| Aug 7, 2026 | Common Stock | Option exercise | 6,542 | US$15.29 | 419,711 | Direct |
| Aug 7, 2026 | Common Stock | Option exercise | 4,995 | US$20.02 | 424,706 | Direct |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Struthers Richard Scott
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Struthers Richard Scott · Sep 1, 2026
- Form 4 · Struthers Richard Scott · Jun 2, 2026
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026